QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron 期刊论文 2018, 卷号: 72, 期号: 16, 页码: C120-C120 作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin 收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03 Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron 会议论文 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018-10-16 作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03 A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents 期刊论文 2018, 卷号: 11, 期号: 3, 页码: 260-272 作者:  Han Yaling;  Xu Bo;  Fu Guosheng;  Wang Xiaozeng;  Xu Kai 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 bioresorbable scaffolds  drug-eluting stent(s)  randomized controlled trial   Impact of Completeness of Revascularization in Complex Coronary Artery Disease as Measured With the SYNTAX Revascularization Index: An SEEDS Substudy 期刊论文 2017, 卷号: 89, 期号: ,SI, 页码: 541-548 作者:  Xu, Bo;  Bettinger, Nicolas;  Guan, Changdong;  Redfors, Bjorn;  Yang, Yuejin 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 SYNTAX score  SYNTAX revascularization index  reasonable revascularization  coronary artery disease  percutaneous coronary intervention   Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients 期刊论文 2016, 卷号: 95, 期号: 30, 页码: e4342 作者:  Wang, Xiaojian;  Zhu, Ling;  Wu, Yan;  Sun, Kai;  Su, Ming 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 first-ever stroke  growth differentiation factor 15  hypertension